Euglycemic diabetic ketoacidosis after discontinuing SGLT2 inhibitor

M Alhemeiri, E Alseddeeqi - Case Reports in Endocrinology, 2022 - Wiley Online Library
Background. Sodium glucose cotransporter‐2 (SGLT2) inhibitors have been proven to be
very effective in the management of type II diabetes. These medications can cause adverse …

[PDF][PDF] Euglycemic Diabetic Ketoacidosis after Discontinuing SGLT2 Inhibitor

M Alhemeiri, E Alseddeeqi - 2022 - scienceopen.com
Background. Sodium glucose cotransporter-2 (SGLT2) inhibitors have been proven to be
very effective in the management of type II diabetes. ese medications can cause adverse …

[HTML][HTML] Euglycemic Diabetic Ketoacidosis after Discontinuing SGLT2 Inhibitor

M Alhemeiri, E Alseddeeqi - Case Reports in Endocrinology, 2022 - ncbi.nlm.nih.gov
Background Sodium glucose cotransporter-2 (SGLT2) inhibitors have been proven to be
very effective in the management of type II diabetes. These medications can cause adverse …

Euglycemic Diabetic Ketoacidosis after Discontinuing SGLT2 Inhibitor

M Alhemeiri, E Alseddeeqi - Case Reports in Endocrinology, 2022 - nchr.elsevierpure.com
Background. Sodium glucose cotransporter-2 (SGLT2) inhibitors have been proven to be
very effective in the management of type II diabetes. These medications can cause adverse …

[引用][C] Euglycemic Diabetic Ketoacidosis after Discontinuing SGLT2 Inhibitor

M Alhemeiri, E Alseddeeqi - Case Reports in Endocrinology (Web), 2022 - jglobal.jst.go.jp
Euglycemic Diabetic Ketoacidosis after Discontinuing SGLT2 Inhibitor | Article Information | J-GLOBAL
Art J-GLOBAL ID:202202215402525718 Reference number:22A1039557 Euglycemic …

Euglycemic Diabetic Ketoacidosis after Discontinuing SGLT2 Inhibitor

M Alhemeiri, E Alseddeeqi - Case Reports in Endocrinology, 2022 - search.proquest.com
Background. Sodium glucose cotransporter-2 (SGLT2) inhibitors have been proven to be
very effective in the management of type II diabetes. These medications can cause adverse …

Euglycemic Diabetic Ketoacidosis after Discontinuing SGLT2 Inhibitor.

M Alhemeiri, E Alseddeeqi - Case Reports in Endocrinology, 2022 - europepmc.org
Background Sodium glucose cotransporter-2 (SGLT2) inhibitors have been proven to be
very effective in the management of type II diabetes. These medications can cause adverse …

Euglycemic Diabetic Ketoacidosis after Discontinuing SGLT2 Inhibitor.

M Alhemeiri, E Alseddeeqi - Case Reports in Endocrinology, 2022 - search.ebscohost.com
Abstract Background. Sodium glucose cotransporter-2 (SGLT2) inhibitors have been proven
to be very effective in the management of type II diabetes. These medications can cause …

Euglycemic Diabetic Ketoacidosis after Discontinuing SGLT2 Inhibitor

M Alhemeiri, E Alseddeeqi - Case reports in …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Sodium glucose cotransporter-2 (SGLT2) inhibitors have been proven to be
very effective in the management of type II diabetes. These medications can cause adverse …

Euglycemic Diabetic Ketoacidosis after Discontinuing SGLT2 Inhibitor.

M Alhemeiri, E Alseddeeqi - Case Reports in Endocrinology, 2022 - europepmc.org
Background Sodium glucose cotransporter-2 (SGLT2) inhibitors have been proven to be
very effective in the management of type II diabetes. These medications can cause adverse …